Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Roles of Albumin‐Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery

Pengfei ZhaoState Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences 501 Haike Road Shanghai 201203 P.R. ChinaYonghui WangState Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences 501 Haike Road Shanghai 201203 P.R. ChinaAihua WuState Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences 501 Haike Road Shanghai 201203 P.R. ChinaYuefeng RaoThe First Affiliated Hospital of the College of Medicine Zhejiang University Hangzhou 310003 P.R. ChinaYongzhuo HuangState Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences 501 Haike Road Shanghai 201203 P.R. China
2018en
ABI

Аннотация

Nutrient transporters have attracted significant attention for their promising application in biomimetic delivery. Due to the active consumption of nutrients, cancer cells generally overexpress nutrient transporters to meet their increased need for energy and materials. For example, albumin-binding proteins (ABPs) are highly overexpressed in malignant cells, stromal cells, and tumor vessel endothelial cells responsible for albumin uptake. ABP (e.g., SPARC) is a promising target for tumor-specific drug delivery, and albumin has been widely used as a biomimetic delivery carrier. Apart from the transportation function, ABPs are closely associated with neoplasia, invasion, and metastasis. Herein, a summary of the roles of ABP in cancer progression and the application of albumin-based biomimetic tumor-targeted delivery through the ABP pathway is presented.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0